• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Celgene Corporation (CELG)

    -NasdaqGS
    116.48 Up 3.66(3.24%) Dec 18, 4:00PM EST
    |After Hours : 116.65 Up 0.17 (0.15%) Dec 18, 7:50PM EST
    Add to Portfolio
    Prev Close:112.82
    Open:115.50
    Bid:85.00 x 200
    Ask:N/A
    1y Target Est:116.68
    Beta:2
    Next Earnings Date:29-Jan-15CELG Earnings announcement
    Day's Range:114.56 - 116.50
    52wk Range:66.85 - 119.84
    Volume:6,100,915
    Avg Vol (3m):5,137,380
    Market Cap:93.03B
    P/E (ttm):61.02
    EPS (ttm):1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 3.24%93.03B
    JNJUp 2.63%298.97B

    Key Statistics

    Forward P/E (1 yr):23.97
    P/S (ttm):12.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.68
    Quarterly EPS Est (Dec-14) :1.00
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.23

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback